British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...

Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

Means couldn’t defend the anti-vaxxism either, apparently. Instead of making his case with facts, Means pretended RFK Jr. is not anti-vaccine, then attacked the physicians alarmed about the spread of ...

Many cat owners overfeed their pets without realizing it, leading to obesity, health issues, and decreased energy levels. If ...

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

NEWARK, CA / ACCESS Newswire / February 21, 2025 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today reported financial results for the fourth quarter and full year ended ...

Obesity affects over a third of Missouri's adults and children, with rural areas hit hardest. It's a complex issue linked to mental health and accessibility, not just personal choice.